Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Alice S Mims

37PUBLICATIONS
226CO-AUTHORS
Solid tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

Sort by Publication Date:
|May 20, 2026
RAS pathway activation and microenvironmental adaptation as hallmarks of myeloid sarcoma.

|Mar 06, 2026
Enhancing tyrosine kinase inhibitor sensitivity by restoring IKAROS activity on GLUT1 expression and glycolysis in Philadelphia chromosome-positive acute lymphoblastic leukemia.

Linyao Zhang, Qi Han, Huimin Xiang

|Feb 03, 2026
Clinical outcomes of older patients with NPM1-mutated or KMT2A-rearranged AML before menin inhibitors: a Beat AML report.

Joshua F Zeidner, Jayanshu Jain, Rina Li Welkie

|Sep 30, 2025
Inotuzumab Ozogamicin Then Blinatumomab for Older Adults With Newly Diagnosed B-Cell ALL: Alliance Study A041703 Cohort 1 Results.

Matthew J Wieduwilt, Jun Yin, Oudom Kour

|Sep 19, 2025
Multi-dimensional analysis of adult acute myeloid leukemia cross-continents reveals age-associated trends in mutational landscape and treatment outcomes (Acute Myeloid Leukemia Cooperative Group & Alliance for Clinical Trials in Oncology).

Monica Cusan, Karilyn Larkin, Deedra Nicolet

|Jun 25, 2025
A Phase 1b/2 Study of TP-0903 and Decitabine Targeting Mutant TP53 and/or Complex Karyotype in Patients with Untreated Acute Myeloid Leukemia ≥Age 60 Years.

Eric D Eisenmann, Ronan Swords, Ying Huang

Pageof 7

Frequent Collaborators

11 joint publications

James S Blachly

9 joint publications

Brian J Druker

7 joint publications

Krzysztof Mrózek

7 joint publications

Shelley Orwick

6 joint publications

Yazan Madanat

6 joint publications

Tara Lin

5 joint publications

Ann-Kathrin Eisfeld

5 joint publications

Joshua Zeidner

4 joint publications

Deedra Nicolet

4 joint publications

Mark R Litzow

Frequent Collaborators

11 joint publications

James S Blachly

9 joint publications

Brian J Druker

7 joint publications

Krzysztof Mrózek

7 joint publications

Shelley Orwick